Trials / Conditions / Nonproliferative Diabetic Retinopathy
Nonproliferative Diabetic Retinopathy
4 registered clinical trials studyying Nonproliferative Diabetic Retinopathy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR) NCT05383209 | EyePoint Pharmaceuticals, Inc. | Phase 2 |
| Completed | The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Prolifera NCT03197870 | EyePoint Pharmaceuticals, Inc. | Phase 2 |
| Completed | Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy NCT02834663 | Wonkwang University Hospital | Phase 4 |
| Completed | Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to NCT02718326 | Regeneron Pharmaceuticals | Phase 3 |